
A recent narrative review has highlighted the growing threat posed by the animal tranquilizer xylazine, also known as tranq, found in illicitly manufactured fentanyl. The review underscores the urgent need for expanded testing and increased understanding of its effects. Xylazine is commonly added to illegal opioids, especially fentanyl, potentially intensifying their impact. Users experience zombie-like states, slowed breathing, and skin ulcers. Traditional antidotes like naloxone are ineffective against xylazine, and the White House has declared it an "emerging threat." The review calls for more research, provider education, and expanded testing protocols.
Like
Save
Share